Middle East Cell Therapy Raw Materials Market To Reach $169.8 Million By 2033

Middle East Cell Therapy Raw Materials Market Growth & Trends

The Middle East cell therapy raw materials market size is projected to reach USD 169.8 million by 2033, growing at a CAGR of 17.8% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is growing steadily, driven by increasing demand for high-quality reagents, media, and consumables to support regenerative medicine, immunotherapy, and advanced cell-based research. As regional governments invest in biotechnology, translational medicine, and life sciences innovation, cell therapy raw materials are central to initiatives aimed at improving clinical outcomes, accelerating therapy development, and supporting scalable manufacturing. Applications in CAR?T therapies, stem cell treatments, and tissue engineering are particularly fueling market momentum across the region.

Technological advancements in GMP-grade media, chemically defined reagents, automated cell culture systems, and bioprocessing solutions make cell therapy manufacturing more efficient, reproducible, and cost-effective, supporting research and clinical applications. Moreover, strong government support, the establishment of cell therapy centers, and international collaborations, especially in the UAE, Saudi Arabia, and Qatar, are driving regional demand and encouraging companies to expand distribution, partnerships, and local support networks within the Middle East's growing regenerative medicine ecosystem.

With rising interest in personalized therapies, allogeneic and autologous cell treatments, and scalable manufacturing solutions, the Middle East cell therapy raw materials market is well-positioned to support the next generation of regenerative medicine and immunotherapy innovation. Continued investment in infrastructure, regulatory harmonization, and public-private collaborations will be critical in unlocking the full potential of cell therapy technologies across the region.

 Request a free sample copy or view report summary: Middle East Cell Therapy Raw Materials Market Report

Middle East Cell Therapy Raw Materials Market Report Highlights

• By product, cell culture supplements dominated the Middle East cell therapy raw materials market in 2024, accounting for the largest share of 25.29%. The widespread use of supplements such as growth factors, cytokines, and serum-free media in expanding, differentiating, and maintaining stem cells, immune cells, and other therapeutic cell types drives this dominance. The reliability, consistency, and GMP compliance of these supplements continue to make them essential for research and clinical-grade cell therapy applications.

• By end use, biopharmaceutical and pharmaceutical companies accounted for the largest market share of 53.70% in 2024, reflecting the sector's growing reliance on high-quality raw materials for developing cell therapies, CAR?T treatments, and regenerative medicine products. These companies use raw materials from cell therapy to support clinical-grade cell expansion, process standardization, and manufacturing scale-up. With increasing investments in local production, clinical trials, and personalized medicine initiatives, biopharma and pharmaceutical firms are expanding their use of cell therapy consumables, positioning themselves as key drivers of market growth across the Middle East.

Middle East Cell Therapy Raw Materials Market Segmentation

Grand View Research has segmented the Middle East cell therapy raw material market based on product, end use, and country:

Middle East Cell Therapy Raw Materials Product Scope Outlook (Revenue, USD Million, 2021 - 2033)

• Media

• Sera

• Cell Culture Supplements

• Antibodies

• Reagents & Buffers

• Others

Middle East Cell Therapy Raw Materials End Use Scope Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceutical & Pharmaceutical Companies

• CROs & CMOs

• Others

Middle East Cell Therapy Raw Materials Country Outlook (Revenue, USD Million, 2021 - 2033)

• Middle East

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

  • Rest of Middle East

List of Key Players in the Middle East Cell Therapy Raw Materials Market

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Danaher

• Sartorius Stedim Biotech

• Actylis.

• ACROBiosystems

• STEMCELL Technologies.

• Grifols, S.A.

• Charles River Laboratories

• RoosterBio, Inc.

• PromoCell GmbH